NFKB2 and Miyoshi myopathy: To gain insights into the cis-regulatory mechanisms that may be driving such oncogenic transcriptional programmes during aberrant ncNF-κB signalling, we investigated the NF-κB2/p52 occupancy at active enhancers of MM.